This is a funding opportunity (grant) for Cutting-Edge Basic Research Awards (CEBRA) under funding opportunity PAR-25-101 and CFDA 93.279. It is an R21 Clinical Trial Optional award.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.